GOTELLI, EMANUELE
 Distribuzione geografica
Continente #
EU - Europa 4.797
AS - Asia 1.573
NA - Nord America 1.326
SA - Sud America 198
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.930
Nazione #
IT - Italia 4.530
US - Stati Uniti d'America 1.276
SG - Singapore 616
CN - Cina 392
VN - Vietnam 293
BR - Brasile 135
FR - Francia 103
HK - Hong Kong 75
BD - Bangladesh 71
FI - Finlandia 51
AR - Argentina 31
DE - Germania 28
ID - Indonesia 23
JP - Giappone 23
CA - Canada 22
IN - India 21
MX - Messico 21
GB - Regno Unito 18
NL - Olanda 13
ZA - Sudafrica 13
CO - Colombia 10
PH - Filippine 8
SE - Svezia 8
PY - Paraguay 7
RU - Federazione Russa 7
AT - Austria 6
EC - Ecuador 6
TH - Thailandia 6
CL - Cile 5
KE - Kenya 5
PL - Polonia 5
TR - Turchia 5
UZ - Uzbekistan 5
KR - Corea 4
MA - Marocco 4
TN - Tunisia 4
ES - Italia 3
HR - Croazia 3
IQ - Iraq 3
MY - Malesia 3
PK - Pakistan 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
CH - Svizzera 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UA - Ucraina 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
HN - Honduras 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 7.930
Città #
Genoa 3.473
Vado Ligure 458
Singapore 300
St Louis 273
Genova 271
San Jose 223
Rapallo 209
Council Bluffs 103
Lauterbourg 92
Ashburn 89
Ho Chi Minh City 83
Hanoi 75
Hong Kong 72
Beijing 63
New York 61
Boardman 56
Helsinki 41
Los Angeles 36
Frankfurt am Main 16
Santa Clara 16
Mexico City 15
Haiphong 14
Bordighera 13
Da Nang 13
Tokyo 13
Chicago 12
Milan 12
Houston 10
Lappeenranta 10
Jamaica Plain 9
Orem 9
Padua 9
Rome 9
São Paulo 9
Amsterdam 7
Biên Hòa 7
Montreal 7
Vienna 7
Salt Lake City 6
Bắc Giang 5
Dallas 5
Denver 5
Hải Dương 5
Medford 5
Paris 5
Stockholm 5
Tashkent 5
Thái Bình 5
Tianjin 5
Atlanta 4
Baltimore 4
Bangkok 4
Brasília 4
Buffalo 4
Can Tho 4
Cape Town 4
Curitiba 4
Jakarta 4
Johannesburg 4
Mumbai 4
Nairobi 4
Naples 4
Phoenix 4
Seattle 4
Thái Nguyên 4
Warsaw 4
Washington 4
Asunción 3
Baghdad 3
Bogotá 3
Buenos Aires 3
Bắc Ninh 3
Chennai 3
City of London 3
Detroit 3
Elk Grove Village 3
Gwynn Oak 3
Hangzhou 3
Lisbon 3
London 3
Manaus 3
Manchester 3
Miami 3
Nagīna 3
Ninh Bình 3
Nuremberg 3
Philadelphia 3
Piscataway 3
Quito 3
Rio de Janeiro 3
Santo André 3
Schiffdorf 3
Serra 3
Toronto 3
Tunis 3
Zagreb 3
Baku 2
Belgrade 2
Bengaluru 2
Bragança Paulista 2
Totale 6.418
Nome #
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases 162
Lower urinary tract symptoms in systemic sclerosis: a detailed investigation. 135
Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey 131
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings 125
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 123
A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions 122
Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease 119
Interaction between microbiota , diet/nutrients and immune/inflammatory response in rheumatic disease: focus on rheumatoid artrthris 119
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease 117
The epigenetic effects of glucocorticoids, sex hormones and vitamin D as steroidal hormones in rheumatic musculoskeletal diseases 116
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 115
Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms 115
Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic 115
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review 108
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography 108
CHARACTERIZATION OF MONOCYTE/MACROPHAGE CELL POPULATIONS IN PERIPHERAL BLOOD AND IN THE LUNG TISSUE OF SYSTEMIC SCLEROSIS PATIENTS 106
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients 105
Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update 102
Full longitudinal nailfold videocapillaroscopy analysis of microvascular changes during normal pregnancy 102
Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 99
Nailfold videocapillaroscopy in juvenile dermatomyositis: detailed correlations between microvascular abnormalities with clinical and laboratory parameters from an observational retrospective single-center study 99
Microvascular status and skin thickness in adults with hypermobile Ehlers-Danlos syndrome: a pilot investigation 98
Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease. 98
Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients 98
Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update 98
POS1087 Heart involvement evaluation by speckle-tracking global longitudinal strain as further predictor of organ damage in Systemic Sclerosis according to microvascular status 95
AB0354 FDG-PET-DETECTED LARGE VESSEL VASCULITIS DOES NOT PREDICT DISEASE OUTCOME IN PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA 92
Understanding the value of non-specific abnormal capillary dilations in presence of Raynaud's phenomenon: a detailed capillaroscopic analysis. 89
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system. 89
POS0394 AMINAPHTONE SHORT-TERM TREATMENT REDUCES TGF-BETA PLASMA LEVELS IN SYSTEMIC SCLEROSIS PATIENTS WITH SECONDARY RAYNAUD’S PHENOMENON 87
Vitamin D and Lung Outcomes in Elderly COVID-19 Patients 86
Engineered glove to evaluate hand disability in rheumatoid arthritis: A pilot-study 86
AB0438 SERUM HOMOCYSTEINE AND BONE STATUS IN SYSTEMIC SCLEROSIS PATIENTS 85
POS0645 NAILFOLD VIDEOCAPILLAROSCOPY AS MARKER OF MICROVASCULAR STATUS IN RHEUMATOID ARTRITIS MAY ALSO IDENTIFY THE CONCOMITANT PRESENCE OF OVERLAP SYNDROMES 84
Vitamin D and Muscle Status in Inflammatory and Autoimmune Rheumatic Diseases: An Update 83
Immune system activation in polymyalgia rheumatica: Which balance between autoinflammation and autoimmunity? A systematic review 81
Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients. 80
Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis. 79
AB0080 IMBALANCE OF MONOCYTE/MACROPHAGE POLARIZATION IN PERIPHERAL BLOOD AND SYNOVIAL FLUID OF RHEUMATOID ARTHRITIS PATIENTS 78
AB0374 LUPUS LOW DISEASE ACTIVITY STATE AND MAINTAINING DRUG THERAPY: A RETROSPECTIVE INVESTIGATION 77
AB0092 CTLA4-Ig PROMOTES THE M1-M2 SHIFT IN CULTURED MACROPHAGES OF RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE: IN VITRO STUDY 76
AB0578 LONG-TERM TOLERABILITY OF AMINAPHTONE IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS IN CONCOMITANT STANDARD THERAPY 75
Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging 74
Microvascular status in juvenile Sjögren's disease: the first nailfold videocapillaroscopy investigation 74
POS0132 POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS INDUCED BY IMMUNE CHECKPOINT INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS REVEALING KEY DIFFERENCES WITH THE IDIOPATHIC FORMS 74
AB1160 IMPACT OF COVID-19 TREATMENTS ON PERIPHERAL CAPILLARY DENSITY EVALUATED BY NAILFOLD VIDEOCAPILLAROSCOPY 73
AB1210 FIBROMYALGIA AND BODY MASS COMPOSITION IN POST-MENOPAUSAL WOMEN: PRELIMINARY RESULTS FROM A CROSS-SECTIONAL MONOCENTRIC STUDY 73
Differences in nailfold capillaroscopy findings between limited and diffuse cutaneous systemic sclerosis: a detailed analysis 72
The dichotomy of glucocorticosteroid treatment in immuneinflammatory rheumatic diseases: an evidence-based perspective and insights from clinical practice 71
POS0862 NAILFOLD CAPILLAROSCOPY IN UNDIFFERENTIATED AND MIXED CONNECTIVE TISSUE DISEASES 71
POS1250 VITAMIN D DEFICIENCY IS MAINLY ASSOCIATED WITH SEVERE LUNG INVOLVEMENT, LONGER DISEASE DURATION AND RISK OF DEATH IN ELDERLY COVID-19 PATIENTS 71
POS0568 Progressive microvascular abnormalities detectable overtime by nailfold videocapillaroscopy in long-COVID patients: a multicenter Italian investigation 70
FRI0257 CAPILLAROSCOPIC VERY EARLY MORPHOLOGICAL AND QUANTITATIVE SPECIFIC ABNORMALITIES ANTICIPATE THE DEVELOPMENT OF THE “SCLERODERMA PATTERN” IN PATIENTS WITH RAYNAUD'S PHENOMENON 68
AB0168 NINTEDANIB (TYROSINE-KINASE INHIBITOR) INHIBITS THE TRANSITION OF CIRCULATING FIBROCYTES ISOLATED FROM SYSTEMIC SCLEROSIS PATIENTS INTO MYOFIBROBLASTS: AN IN VITROSTUDY 68
POS1337 CLINICAL OUTCOMES OF METHOTREXATE TREATMENT FOR IMMUNE CHECKPOINT INHIBITOR-INDUCED ARTHRITIS IN CANCER PATIENTS: A RETROSPECTIVE LONGITUDINAL PILOT STUDY 68
Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors 67
AB1187 LONG-TERM SAFETY AND EFFICACY OF AMINAPHTONE IN SYSTEMIC SCLEROSIS PATIENTS WITH ACTIVE RAYNAUD’S PHENOMENON 66
AB0330 ANTIPHOSPHOLIPID ANTIBODIES AND ANTICOAGULANT TREATMENT: CAPILLAROSCOPIC FINDINGS 65
AB0057 IN VITRO EFFECT OF CTLA4-IGG ON M1-M2 SHIFT OF MACROPHAGES FROM RHEUMATOID ARTHRITIS PATIENTS 65
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. 65
ABS0404 DIFFERENCES IN NAILFOLD VIDEOCAPILLAROSCOPY ANALYSIS COMPARING LIMITED CUTANEOUS AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A DETAILED, RETROSPECTIVE STUDY 65
An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study 64
Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 64
Influence of Seasonal Vitamin D Changes on Clinical Manifestations of Rheumatoid Arthritis and Systemic Sclerosis 64
SAT0337 EVALUATION OF BODY COMPOSITION AND BONE STATUS ACCORDING TO MICROVASCULAR INVOLVEMENT IN SYSTEMIC SCLEROSIS PATIENTS 63
AB0276 NAILFOLD VIDEO CAPILLAROSCOPY SUPPORT THE DIAGNOSIS OF OVERLAP CONNECTIVE TISSUE DISEASE: A PILOT STUDY IN A SAMPLE OF RHEUMATOID ARTHRITIS PATIENTS 62
AB1437 NAILFOLD CAPILLAROSCOPY IN DEFICIENCY OF ADENOSINE DEAMINASE 2 (DADA2): A CASE-CONTROL STUDY 62
THU0359 GENDER IMPACT ON LOWER URINARY TRACT INVOLVEMENT IN SYSTEMIC SCLEROSIS PATIENTS 62
AB0408 DOES THE PRESENCE IN THE SERUM OF ANTIPHOSPHOLIPID ANTIBODIES CORRELATE WITH SPECIFIC/NON SPECIFIC CAPILLAROSCOPIC ABNORMALITIES? 62
Multicentre retrospective detection of nailfold videocapillaroscopy abnormalities in long covid patients 61
AB0739 Aminaphtone tolerability and safety in scleroderma patients: a four-year follow-up | Annals of the Rheumatic Diseases 61
POS1417 CHOROIDAL THICKNESS AS A NOVEL IMAGING MICROVASCULAR BIOMARKER FOR DISEASE PHENOTYPE IN SYSTEMIC SCLEROSIS: INSIGHTS FROM OCTA, LASCA AND NVC ANALYSES 61
AB0845 INVESTIGATING PERIPHERAL MICROCIRCULATION IN JUVENILE SJÖGREN’S SYNDROME: A PILOT STUDY USING NAILFOLD VIDEOCAPILLAROSCOPY 60
AB0738 Do cosmetic silicone implants trigger systemic sclerosis? | Annals of the Rheumatic Diseases 59
Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19 59
AB0805 DESCRIPTION IN FLOW IN EARLY VERSUS CLINICALLY OVERT SYSTEMIC SCLEROSIS. LASER SPECKLE CONTRAST ANALYSIS: A DESCRIPTIVE STUDY ON THE PERIPHERAL BLOOD OF THE DIFFERENT SUBTYPES OF SYSTEMIC SCLEROSIS 58
SAT0300 SERUM FROM “EARLY” SYSTEMIC SCLEROSIS PATIENTS ALREADY INDUCES THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE (M2) IN CULTURED HUMAN MONOCYTES 58
POS0962 ENGINEERED GLOVE FOR THE OBJECTIVE ASSESSMENT OF HAND DEXTERITY IN SYSTEMIC SCLEROSIS PATIENTS 58
AB1310 UTILIZATION AND ATTITUDES TOWARDS NAILFOLD VIDEOCAPILLAROSCOPY FOR THE ASSESSMENT OF MICROVASCULAR STATUS IN PATIENTS WITH LONG-COVID: A MULTICENTER ONLINE SURVEY 58
AB1564 PERIPHERAL BLOOD PERFUSION IN MCTD AND UCTD PATIENTS: A CROSS-SECTIONAL MONOCENTRIC STUDY 55
Complex role of oestrogens in the risk and severity of rheumatoid arthritis in menopause 53
AB1351 FULL LONGITUDINAL NAILFOLD VIDEOCAPILLAROSCOPY ANALYSIS OF MICROVASCULAR CHANGES DURING NORMAL PREGNANCY 52
AB0679 NAILFOLD VIDEOCAPILLAROSCOPY RESULTS IN COVID-19 PATIENTS RECOVERED FROM DIFFERENT DISEASE SEVERITY 52
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study 51
POS0882 AMINAPHTONE LONG-TERM TREATMENT IN SYSTEMIC SCLEROSIS 50
The importance of neuroendocrine immunology pathways in course of COVID-19 49
Immune-modulatory effects of low oestrogen serum concentrations on the progression of ACPA-negative inflammatory arthritis in postmenopause 49
Clinical outcomes in cancer patients with immune checkpoint inhibitor-induced arthritis treated with methotrexate: a retrospective longitudinal monocentric pilot study 49
Description of Peripheral Blood Perfusion by Laser Speckle Contrast Analysis (LASCA) in ‘Early’ versus ‘Clinically Overt’ Systemic Sclerosis in Routine Clinics 48
Glucocorticoids in rheumatoid arthritis still on first line: the reasons. 48
POS1488-HPR NAILFOLD VIDEOCAPILLAROSCOPY IN JUVENILE DERMATOMYOSITIS: CORRELATIONS BETWEEN MICROVASCULAR ABNORMALITIES AND CLINICAL FEATURES 48
POS0815 ULTRASONOGRAPHY FOR DAY-TO-DAY CLINICAL USE: CONSTRUCTION OF A SIMPLE DISCRIMINATOR BETWEEN HEALTHY SKIN AND THICKENED SYSTEMIC SCLEROSIS SKIN 48
POS0850 NAILFOLD CAPILLARY DILATIONS IN RAYNAUD'S PHENOMENON: QUANTIFYING A PREDICTIVE THRESHOLD FOR THE ‘SCLERODERMA PATTERN‘ 47
Temporomandibular disorders in immune-mediated rheumatic diseases of the adult: A systematic review 47
A matter arising: When should inflammatory and autoimmune rheumatic diseases be considered ‘early’? 46
Updating on pregnancy in rheumatoid arthritis 45
Mapping in healthy subjects different body areas for dermal thickness and skin hardness by high frequency ultrasound and durometry 45
Endogenous and exogenous environmental hormone D (vitamin D) suppliers in autoimmune rheumatic diseases 44
POS0583 ENGINEERED GLOVE TO EVALUATE THE SPEED OF THE HANDS' MOVEMENTS IN RHEUMATOID ARTHRITIS 44
Emerging nailfold capillaroscopic patterns in COVID-19: from acute patients to survivors 44
Totale 7.687
Categoria #
all - tutte 26.870
article - articoli 26.261
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 325
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/2022168 3 13 0 9 10 3 26 30 22 16 12 24
2022/2023277 30 27 5 11 42 29 11 21 38 16 42 5
2023/2024412 21 46 5 53 22 51 22 48 9 19 28 88
2024/20251.329 80 82 59 82 134 108 126 204 40 166 129 119
2025/20265.961 542 424 628 1.114 554 355 588 233 440 657 305 121
Totale 8.279